Clincosm LogoSign in Get a demo

sars

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19, SARS Trial in London (Control group, SLEDD with a L-MOD)

Recruiting
  • COVID-19
  • SARS
  • Control group
  • SLEDD with a L-MOD
  • London, Ontario, Canada
  • +1 more
Apr 28, 2022

Corona Virus Infection, COVID-19, SARS Trial in New York (Zofin, Placebo)

Active, not recruiting
  • Corona Virus Infection
  • +3 more
  • Zofin
  • Placebo
  • New York, New York
    George C. Shapiro
Feb 2, 2022

SARS-CoV 2, SARS Trial in Córdoba (Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA], Sarilumab 400 MG/2.28 ML

Completed
  • SARS-CoV 2
  • SARS
  • Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA]
  • +2 more
  • Córdoba, Spain
    Hospital Universitario Reina Sofía
Jul 6, 2021

Cytokine Release Syndrome (CRS) in COVID-19

Unknown status
  • Covid-19
  • +4 more
  • Wuhan, Hubei, China
    Tongji Hospital
Mar 16, 2020

Collection of Convalescent SARS Plasma by Apheresis

Completed
  • Severe Acute Respiratory Syndrome
  • SARS
    • Hong Kong, China
      The Chinese University of Hong Kong
    Jun 30, 2017

    SARS Trial in Iowa City, Saint Louis, Cincinnati (drug, other, biological)

    Withdrawn
    • SARS
    • Aluminum hydroxide adjuvant (Alhydrogel®)
    • +2 more
    • Iowa City, Iowa
    • +2 more
    Feb 14, 2013

    Cytokine/Chemokine in Severe Acute Respiratory Syndrome

    Completed
    • SARS
      • (no location specified)
      Sep 12, 2005